Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Flexion Mobile - Strong growth in Q3, but below ABGSCe

22 november 2024

<a id="bm-comp-26dda738-4a64-4336-a519-0c6b9d28642e" name="bm-comp-26dda738-4a64-4336-a519-0c6b9d28642e" class="BMCustomAnchor"></a><table><tr><td bm-component-id="26dda738-4a64-4336-a519-0c6b9d28642e" style="vertical-align: top; width:100.000000%;"><ul><li>Strong sales growth in Q3, but 5% below our expectations</li><li>We cut 2025e EBIT 1% but raise 2026e 4% on lower opex</li><li>Share is trading at 7-5x EV/EBITA, 15-10x P/E on '25e-'26e</li></ul></td></tr></table><a id="bm-comp-838246fc-ae91-4a09-9eeb-a932261f55ff" name="bm-comp-838246fc-ae91-4a09-9eeb-a932261f55ff" class="BMCustomAnchor"></a><table><tr><td bm-component-id="838246fc-ae91-4a09-9eeb-a932261f55ff" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Sales +20% y-o-y in Q3, but 5% below ABGSCe</h3><p>Flexion delivered Q3 numbers slightly short of our expectations. Sales of GBP 18m corresponded to a 20% increase y-o-y, but were 5% below ABGSCe, while EBIT was GBP -0.6m vs. ABGSCe GBP 0.6m, impacted by slightly higher depreciations. That being said, Flexion has a strong pipeline, with King's flagship game Candy Crush (top 10 grossing mobile game globally) entering the portfolio, which we expect will have a positive impact on growth in 2025. Management guided for revenue of USD 26-30m in Q4 (GBP 21-24m), which is a tad below our pre-Q3 estimate (GBP 25m). We therefore cut our sales estimates by 5-3% for '25e-'26e. While depreciations have remained elevated near-term, we expect depreciations related to game distribution rights with Scopley to decrease from 2025. We forecast slightly lower opex, which means that we make more limited revisions to EBIT in 2025e (-1%) and slight positive revisions to 2026e (4%) despite slightly lower sales.</p><h3 class="bm-h3">Positive market developments</h3><p>As we have commented before, regulatory pressure on Google and Apple from the EU is forcing them to allow developers to bypass their respective marketplaces, Google Play and App Store. This is something management has said is creating more demand for Flexion's services. Now, we can see that the pressure has continued to increase in Q3, with Epic winning over Google in the US courts, which management views as an important milestone for the industry, potentially now making both the EU and US markets ready for disruption.</p><h3 class="bm-h3">Finally, leaving the audit issues behind</h3><p>We were also happy to see that Flexion's 2023 audit now is completed, with the new auditor siding with Flexion on the issues raised by its former auditor. Based on our updated estimates, the share is now trading at 7-5x EV/EBIT '25e-'26e (15-10x P/E).</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-02-12 Infrea - Cleaning the pipes for future performance Infrea Analys
2026-02-12 INVISIO - Better-than-expected on all items INVISIO Analys
2026-02-12 Fastpartner - Steep cut to run-rate IFPM Fastpartner Analys
2026-02-12 Clavister - Clavister continues to scale Clavister Analys
2026-02-12 OrganoClick - Positive sales in binders, weak els... OrganoClick Analys
2026-02-12 Nilörn - Strong orders, but pressured margins Nilörn Analys
2026-02-12 Ferronordic - Strong U.S. more than offsets Germany Ferronordic Analys
2026-02-12 NYAB - EBIT in line, organic growth remains good NYAB Analys
2026-02-12 Generic - Gross margins up but costs weigh in Q4 Generic Analys
2026-02-12 Coor - More margin improvements in 2026 Coor Analys
2026-02-11 Medicover - Path to 2028 explained Medicover Analys
2026-02-11 Careium - Bittersweet outlook on 2026 Careium Analys
2026-02-11 Catella - Divestment fuels stronger finish to the... Catella Analys
2026-02-11 Careium - Margin pressure to remain in H1'26 Careium Analys
2026-02-11 Prevas - Margins improving as volumes stabilise Prevas Analys
2026-02-11 Coor - Miss from Denmark, but proposes buybacks Coor Analys
2026-02-10 Medicover - A promising trajectory Medicover Analys
2026-02-10 Proact - Earnings resilience remains impressive Proact Analys
2026-02-10 Prevas - Stable quarter closing the year Prevas Analys
2026-02-10 Proact - Cost savings ahead of expectations Proact Analys